Dianthus Therapeutics
Focus: Dianthus Therapeutics is a biotechnology company focused on monoclonal antibody therapeutics for neurology and immunology indications. The company operates as a clinical-stage biotech with a pipeline spanning Phase 2 and Phase 3 programs.
Profile data last refreshed 4h ago · AI intelligence enriched 2w ago
Open Jobs
8+6 this month
Growing — net +6 jobs in 30d
7 jobs added vs 1 removed. Steady team buildout.
Should You Work at Dianthus Therapeutics?
AI assessmentDianthus represents a specialized, high-risk clinical-stage biotech suitable for impact-driven scientists willing to tolerate small team dynamics and financial opacity in exchange for pipeline ownership.
Why Work Here
- Focused pipeline in high-value neurology and immunology markets with multiple Phase 2/3 programs in monoclonal antibodies, a well-established therapeutic modality
Data completeness
4/9 — Basic
Company HealthStrong
Pipeline
Mid-stage
2 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Clips Intervention
Gestational Diabetes MellitusClinical Trials (1)
NCT05800509Gestational Diabetes and Perinatal Depression: an Intervention Program
N/AHelp build intelligence for Dianthus Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.